Adam Lanza, 20, fatally shot 20 first-graders and six educators at Sandy Hook Elementary School on December 14 before killing himself as police arrived. He also killed his mother at their Newtown home before going to the school.
The official said the toxicology tests were completed about five weeks ago and the results were turned over to Danbury State's Attorney Stephen Sedensky III, who is leading the investigation.
The official, who was not authorised to publicly disclose the information and spoke on condition of anonymity, also said at least some victims' relatives were notified of the test results.
In Lanza's case, a separate test was performed for marijuana, which usually isn't part of toxicological reviews, and came back negative, the official said.
The test results, which were first reported by The Hartford Courant last week, leave many questions unanswered.
Search warrants revealed that Lanza lived in a home surrounded by an arsenal of weapons, but authorities haven't revealed whether Lanza had been prescribed medications or whether he was diagnosed with any disorder that could help explain the massacre.
Illegal drugs and prescription medications were not on the lists of items found at Lanza's home, according to the warrants.
A state investigation report on the killings is expected to be publicly released this summer.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
